Letter

Compulsory registration of clinical trials: Maybe European research should be protected

BMJ 2004; 329 doi: 10.1136/bmj.329.7473.1044 (Published 28 October 2004)
Cite this as: BMJ 2004;329:1044.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Ernst A Singer, chairperson (ernst.singer@meduniwien.ac.at),
  2. Christiane Druml, managing director
  1. Ethics Committee of the Medical University of Vienna, Borschkegasse 8b, A-1090 Vienna, Austria
  2. Ethics Committee of the Medical University of Vienna, Borschkegasse 8b, A-1090 Vienna, Austria

    EDITOR—The merits of transparency of clinical research from the ethics point of view are not to be disputed. The request of the International Committee of Medical Editors for a publicly accessible registry seems exaggerated in its present form, and we agree with Abbasi's points.1 2 …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular